Skip to main content
OpenTrials

Clinical trial condition

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma

Explore clinical trials studying Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma trial results

Suspended

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

NCT01810913

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 342 locations
View Trial Details

Related conditions